Please assess the completion status of the following clinical trial:

Trial Title: Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients had schizophrenia (disorganized, catatonic, paranoid, residual, or undifferentiated) that met disease diagnostic criteria as defined in Diagnostic and Statistical Manual of Mental Disorders IV (\[DSM-IV\]~* Requiring new treatment with long-acting risperidone injectable~* Patients were cooperative, reliable, and able to complete all aspects of the protocol~Exclusion Criteria:~* Use of an investigational drug in the past 30 days~* At risk to self or others

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with schizophrenia (Type: None): Long-acting injectable of risperidone given as per the prescription from the prescribing physician (Observational study).

Based on this trial design, predict the completion outcome and termination type (if applicable).